(Total Views: 76)
Posted On: 11/03/2023 4:21:06 PM
Post# of 224616

$BCRX News Article - BioCryst R&D Day Highlights New Diversified Pipeline of First-in-Class/Best-in-Class Therapies with Five Programs Expected in Clinical Development in Next 24 Months | Benzinga https://marketwirenews.com/news-releases/bioc...95432.html


My Twitter: WhyteStocks